[{"uuid": "3b2b190d-030a-38fc-8d80-652cb2d7f2fa", "title": "CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/crdf-stock-soars-robust-efficacy-150500661.html", "providerPublishTime": 1733929500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 620, "height": 393, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W5ve9LofNukkX0a38W9plQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALNY", "PFE"]}, {"uuid": "f315ef6f-b820-3cbc-97f6-28546f4ce5cc", "title": "While institutions own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), retail investors are its largest shareholders with 57% ownership", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/while-institutions-own-25-cardiff-131332157.html", "providerPublishTime": 1734959612, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eZ0FiSKCVDYnTK6X1bRieQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRDF"]}, {"uuid": "b0e9bb45-42a6-3fb0-a4f8-37a4ec72f0e4", "title": "Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cardiff-oncology-crdf-reports-q3-230512760.html", "providerPublishTime": 1731020712, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/w.ILboV799eZj6zbyZJ3SQ--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8iH7sUYRxbYanfZU7fLgpA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "ca9ac109-af89-3d9c-9432-d872f1e8e24b", "title": "Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cardiff-oncology-announces-positive-initial-110000275.html", "providerPublishTime": 1733828400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/vf15Mtzp18uWZuyhpy0nqg--~B/aD02NTM7dz0xMjA1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3f0bd70b97a7a54e30082262935ab7c5", "width": 1205, "height": 653, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BQn9qfbTEGYPwip6qgTaqA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3f0bd70b97a7a54e30082262935ab7c5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRDF"]}, {"uuid": "2d952d34-d578-3289-91b7-66f0cbed94bc", "title": "Cardiff Oncology Reports High Tumor Response in Mid-Stage Onvansertib Trial; Shares Rise Pre-Bell", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/cardiff-oncology-reports-high-tumor-115244286.html", "providerPublishTime": 1733831564, "type": "STORY"}, {"uuid": "34e6d509-a9c8-3955-837c-2f2d14ecd96f", "title": "Cardiff Oncology Reports Promising Phase 2 Trial Results", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/cardiff-oncology-reports-promising-phase-121954052.html", "providerPublishTime": 1733919594, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VfFShRbSXeKd1NWnCc3B2Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JpxXJhOUS620DitHw.ayrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/5c9a5f191a1b61dffcdf2f63fbd4912c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRDF"]}, {"uuid": "743f2f32-b499-39e2-8b40-18eb3b95e703", "title": "Cardiff Oncology Prices Oversubscribed $40 Million Stock Offering", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/cardiff-oncology-prices-oversubscribed-40-125155484.html", "providerPublishTime": 1733835115, "type": "STORY"}, {"uuid": "266febd2-5cbf-3433-b93c-61b946977e0f", "title": "Cardiff Oncology price target raised to $10 from $7 at Piper Sandler", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/cardiff-oncology-price-target-raised-115008910.html", "providerPublishTime": 1734177008, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/mZDcjNmmKhClNQkla1p5GA--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/d622151edd421d0d1465b02718e80caa", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JR57pJ12h3k1wjWsvT64Rw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/d622151edd421d0d1465b02718e80caa", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRDF"]}, {"uuid": "717abff8-659d-38ad-beb4-b22baa1f186f", "title": "Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cardiff-oncology-prices-oversubscribed-40-122000839.html", "providerPublishTime": 1733833200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/iV8IhhqWKxMiu15YAYM7DQ--~B/aD0xMDk7dz0zNjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c5142a016209ca7fa021d05b94446c6a", "width": 368, "height": 109, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/rGtbBn7oAitYDUMDVcm_0g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c5142a016209ca7fa021d05b94446c6a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRDF"]}, {"uuid": "b26a1d08-81d0-3592-a934-87c746990c44", "title": "What's Going On With Cardiff Oncology Stock On Tuesday?", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/whats-going-cardiff-oncology-stock-151617418.html", "providerPublishTime": 1733843777, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nn8yjTQ7svunKxaKVE5hFw--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/15fb34ece7ab5e589483dd8be501e6a2", "width": 983, "height": 553, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/THLtFg4ICGvSzPVVNgQZ5Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/15fb34ece7ab5e589483dd8be501e6a2", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "37b137fe-6a5a-38ba-8b7f-707431eaeb14", "title": "Update: Cardiff Oncology Shares Surge After Report of High Tumor Response in Mid-Stage Onvansertib Trial", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/cardiff-oncology-shares-surge-report-165004009.html", "providerPublishTime": 1733849404, "type": "STORY"}, {"uuid": "beca726b-59d8-356e-a214-f472594297a6", "title": "Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biotech-stock-roundup-bioa-down-145500028.html", "providerPublishTime": 1733928900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W_dXstIrgNfujttWWGqEAw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["INCY", "QURE"]}]